Ambros Therapeutics and Werewolf Therapeutics agreed to combine in an all-stock transaction and will begin trading on Nasdaq.

The entities involved

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• Fulcrum Therapeutics and Slate Medicines announced a merger to advance next-generation therapeutics and will list on Nasdaq.Aug 17
• uniQure N.V. traded on the Nasdaq stock exchange and submitted a Biologics License Application (BLA) for accelerated approval of its gene therapy.Sep 9
• BioCryst Pharmaceuticals traded on the NASDAQ electronic stock exchange on September 12, 2026.Sep 12
• Palvella Therapeutics, Inc. stock is trading on the Nasdaq exchange, and the NDA review for its product QTORIN is currently underway.Aug 4
• Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.Aug 19